What the Top 10 Biopharma CEOs Are Making
Surging Markets Drive Double- and Triple-Digit Percentage Gains for Compensation
Exosomes from Cancer Cells Could Predict Immunotherapy Responses
Immune-Evasion Mechanism May Help Explain the Differences in Responses to Immunotherapy
Commercializing Gene Therapies
Using High-Touch Services to Enhance Patient Outcomes
Bioreactors Pull Out Some of the Stops
Balancing Bioreactor and Process Parameters Avoids Production Discord and Amplifies Flows
For full access to this article login to GEN Select now.
Supplement: CRISPR Enters the Clinic
Using CRISPR-Altered Cells to Fight Disease
- The CRISPR revolution—which is bringing even nonexperts the ability to rapidly edit genetic material with pinpoint precision—is beginning to infiltrate the clinic. Standing on the shoulders of gene therapy , cell therapy, and bone marrow transplantation, several groups in the United States and Europe are now gearing up to ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.